Published in Gene Therapy Weekly, September 1st, 2005
"Neuregulin-1 (NRG-1) binding to the human epidermal growth factor receptor HER2/HER3 plays a role in pulmonary epithelial cell proliferation and recovery from injury in vitro. We hypothesized that activation of HER2/HER3 by NRG-1 would also play a role in recovery from in vivo lung injury," wrote D.E. Nethery and colleagues, University of Cleveland Hospital.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.